<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosome studies were done in 104 patients with various stages of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>): 10 had <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, 28 had post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> with <z:mpath ids='MPATH_173'>myeloid metaplasia</z:mpath> (PPVMM), 12 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, and 54 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Chromosome studies were successful in 86 patients, 37 (43%) of whom had a chromosome abnormality </plain></SENT>
<SENT sid="2" pm="."><plain>At diagnosis, 4 of 28 patients (14%) had an abnormal clone; the incidence was 78% in PPVMM and 100% in <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Among the 63 patients with successful chromosome studies during the first 10 years of disease, 27% had an abnormal clone </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, of the 23 patients who had the disease for more than 10 years, 87% had an abnormal clone </plain></SENT>
<SENT sid="5" pm="."><plain>Chromosome abnormalities were found in 11 of the 60 patients who either were untreated or underwent only phlebotomy and in 26 of the 44 patients who were treated with myelosuppressive agents </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8, +9, and 20q- were found in some patients early during the course of their disease and also among untreated patients </plain></SENT>
<SENT sid="7" pm="."><plain>These chromosome abnormalities seem to be related to the natural course of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> rather than to therapy </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with a chromosomally abnormal clone at the time of diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> had a poorer survival than did those with only <z:mpath ids='MPATH_458'>normal</z:mpath> metaphases </plain></SENT>
<SENT sid="9" pm="."><plain>Cytogenetic results did not predict evolution of the disease, but they did provide clues to hematologic phenotype, duration of the disease, and consequences of myelosuppressive therapy </plain></SENT>
</text></document>